CLOVES syndrome
MONDO:0013038A syndromic disease characterized by Congenital Lipomatous Overgrowth, progressive, complex and mixed truncal Vascular malformations, Epidermal nevi, and Skeletal anomaly.
Also known as: CLOVE syndrome, somatic, CLOVES syndrome, congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome, congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome, CLOVE syndrome, congenital lipomatous overgrowth - vascular malformation - epidermal nevi, congenital lipomatous overgrowth, vascular malformations, Epidermal nevi, and skeletal/spinal abnormalities
1439 clinical trials for this condition and its sub-types, 5 tagged with CLOVES syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug targets root cause of rare overgrowth syndromes
Disease control Recruiting nowThis Phase 2 study tests an oral drug called RLY-2608 in adults and children with overgrowth conditions (like CLOVES or Klippel-Trenaunay syndrome) caused by PIK3CA gene mutations. The drug is designed to block the faulty protein driving abnormal tissue growth. The trial will enr…
Phase 2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New pill could shrink abnormal vessels in rare childhood disorders
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called KP-001 in 150 people aged 2 and older with venous malformations, lymphatic malformations, or KTS/CLOVES syndrome. Participants receive either KP-001 or a placebo for 24 weeks, then everyone gets the drug for another 28 weeks. The goal …
Phase 3 • Sponsor: Kaken Pharmaceutical • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Scientists launch global effort to unravel mysteries of rare lymphatic diseases
Knowledge-focused Recruiting nowThis study is creating a registry of up to 1,000 people with rare lymphatic system disorders. Researchers will collect information from medical records and yearly surveys to understand how these diseases progress, what treatments are used, and how they affect quality of life. The…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC